nodes	percent_of_prediction	percent_of_DWPC	metapath
Metocurine—CHRND—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—Parkinson's disease	0.0479	0.0589	CbGpPWpGaD
Metocurine—CHRNA1—tongue—Parkinson's disease	0.0367	0.197	CbGeAlD
Metocurine—CHRNA1—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0333	0.0409	CbGpPWpGaD
Metocurine—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0316	0.0389	CbGpPWpGaD
Metocurine—CHRND—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0311	0.0382	CbGpPWpGaD
Metocurine—CHRNA1—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0284	0.0349	CbGpPWpGaD
Metocurine—CHRND—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.0275	0.0338	CbGpPWpGaD
Metocurine—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0269	0.0331	CbGpPWpGaD
Metocurine—CHRNA1—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0265	0.0325	CbGpPWpGaD
Metocurine—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA4—Parkinson's disease	0.0251	0.0309	CbGpPWpGaD
Metocurine—CHRNA1—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.0234	0.0287	CbGpPWpGaD
Metocurine—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA4—Parkinson's disease	0.0222	0.0273	CbGpPWpGaD
Metocurine—CHRND—cardiovascular system—Parkinson's disease	0.0158	0.0846	CbGeAlD
Metocurine—CHRNA2—forebrain—Parkinson's disease	0.0129	0.0693	CbGeAlD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.0099	0.0122	CbGpPWpGaD
Metocurine—CHRNA1—head—Parkinson's disease	0.00892	0.0478	CbGeAlD
Metocurine—CHRND—Neuronal System—HCN3—Parkinson's disease	0.00885	0.0109	CbGpPWpGaD
Metocurine—CHRNB1—medulla oblongata—Parkinson's disease	0.00869	0.0466	CbGeAlD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00855	0.0105	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00842	0.0104	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.008	0.00983	CbGpPWpGaD
Metocurine—CHRNB1—midbrain—Parkinson's disease	0.00794	0.0426	CbGeAlD
Metocurine—CHRNB1—spinal cord—Parkinson's disease	0.00775	0.0416	CbGeAlD
Metocurine—CHRM2—forebrain—Parkinson's disease	0.00771	0.0413	CbGeAlD
Metocurine—CHRNA1—Neuronal System—HCN3—Parkinson's disease	0.00753	0.00925	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00744	0.00915	CbGpPWpGaD
Metocurine—CHRNA2—head—Parkinson's disease	0.0074	0.0397	CbGeAlD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00727	0.00893	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—HCN3—Parkinson's disease	0.00715	0.00879	CbGpPWpGaD
Metocurine—CHRNA2—nervous system—Parkinson's disease	0.00702	0.0376	CbGeAlD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00691	0.00849	CbGpPWpGaD
Metocurine—CHRNB1—head—Parkinson's disease	0.00689	0.0369	CbGeAlD
Metocurine—CHRNA2—central nervous system—Parkinson's disease	0.00676	0.0362	CbGeAlD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00669	0.00822	CbGpPWpGaD
Metocurine—CHRNA2—cerebellum—Parkinson's disease	0.0066	0.0354	CbGeAlD
Metocurine—CHRM2—cardiovascular system—Parkinson's disease	0.00652	0.035	CbGeAlD
Metocurine—CHRNA1—brain—Parkinson's disease	0.00646	0.0347	CbGeAlD
Metocurine—CHRND—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00643	0.0079	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00633	0.00778	CbGpPWpGaD
Metocurine—CHRNB1—cerebellum—Parkinson's disease	0.00615	0.033	CbGeAlD
Metocurine—CHRNA2—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00601	0.00739	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—KCNJ4—Parkinson's disease	0.0057	0.00701	CbGpPWpGaD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00569	0.00699	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00569	0.00699	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00546	0.00672	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.0054	0.00664	CbGpPWpGaD
Metocurine—CHRNA2—brain—Parkinson's disease	0.00536	0.0288	CbGeAlD
Metocurine—CHRNA2—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00519	0.00638	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00503	0.00618	CbGpPWpGaD
Metocurine—CHRNB1—brain—Parkinson's disease	0.00499	0.0268	CbGeAlD
Metocurine—CHRND—Neuronal System—DLG1—Parkinson's disease	0.00492	0.00605	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—KCNJ4—Parkinson's disease	0.00485	0.00596	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00484	0.00594	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—KCNJ4—Parkinson's disease	0.00461	0.00566	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00459	0.00565	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—HTR1A—Parkinson's disease	0.00453	0.00556	CbGpPWpGaD
Metocurine—CHRM2—head—Parkinson's disease	0.00441	0.0237	CbGeAlD
Metocurine—CHRM2—Monoamine GPCRs—DRD1—Parkinson's disease	0.00437	0.00537	CbGpPWpGaD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00436	0.00536	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00428	0.00526	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00428	0.00526	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00426	0.00524	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—DRD3—Parkinson's disease	0.00423	0.0052	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—DLG1—Parkinson's disease	0.00419	0.00515	CbGpPWpGaD
Metocurine—CHRM2—nervous system—Parkinson's disease	0.00419	0.0224	CbGeAlD
Metocurine—CHRND—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00414	0.00509	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00406	0.00499	CbGpPWpGaD
Metocurine—CHRM2—central nervous system—Parkinson's disease	0.00403	0.0216	CbGeAlD
Metocurine—CHRNA2—Neuronal System—DLG1—Parkinson's disease	0.00398	0.00489	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—GRIK1—Parkinson's disease	0.00385	0.00474	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—DRD2—Parkinson's disease	0.00383	0.00471	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—HTR7—Parkinson's disease	0.00383	0.00471	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.0038	0.00468	CbGpPWpGaD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00375	0.00461	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00371	0.00456	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.00367	0.00452	CbGpPWpGaD
Metocurine—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00367	0.00451	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00364	0.00447	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.00356	0.00437	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00352	0.00433	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00352	0.00433	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00345	0.00425	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00335	0.00411	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00328	0.00403	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—GRIK2—Parkinson's disease	0.00328	0.00403	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—GRIK1—Parkinson's disease	0.00328	0.00403	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00323	0.00397	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.00322	0.00396	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.00322	0.00396	CbGpPWpGaD
Metocurine—CHRM2—brain—Parkinson's disease	0.0032	0.0172	CbGeAlD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00319	0.00392	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—SLC18A2—Parkinson's disease	0.00317	0.0039	CbGpPWpGaD
Metocurine—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00312	0.00383	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GRIK1—Parkinson's disease	0.00311	0.00383	CbGpPWpGaD
Metocurine—CHRNA1—ErbB2/ErbB3 signaling events—MAPK8—Parkinson's disease	0.00307	0.00377	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—GRK6—Parkinson's disease	0.00307	0.00377	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00303	0.00372	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.003	0.00369	CbGpPWpGaD
Metocurine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00296	0.00364	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00282	0.00347	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00279	0.00343	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—GRIK2—Parkinson's disease	0.00279	0.00342	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00276	0.00339	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00272	0.00334	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—SLC18A2—Parkinson's disease	0.0027	0.00332	CbGpPWpGaD
Metocurine—CHRM2—Monoamine GPCRs—HTR2A—Parkinson's disease	0.00268	0.0033	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00265	0.00325	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GRIK2—Parkinson's disease	0.00265	0.00325	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—SLC18A2—Parkinson's disease	0.00256	0.00315	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00255	0.00314	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—GRK5—Parkinson's disease	0.00254	0.00312	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—CHRNA4—Parkinson's disease	0.00251	0.00309	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00243	0.00298	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.0024	0.00295	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00234	0.00288	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—ADORA2A—Parkinson's disease	0.00232	0.00285	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00231	0.00284	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00231	0.00284	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—HSPA8—Parkinson's disease	0.0023	0.00283	CbGpPWpGaD
Metocurine—CHRND—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00229	0.00282	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00228	0.0028	CbGpPWpGaD
Metocurine—CHRM2—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00225	0.00277	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00223	0.00274	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00219	0.0027	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00216	0.00266	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—DLG4—Parkinson's disease	0.00216	0.00265	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—CHRNA4—Parkinson's disease	0.00213	0.00262	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—GRIN2B—Parkinson's disease	0.00211	0.00259	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—SLC6A3—Parkinson's disease	0.00208	0.00256	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CHRNA4—Parkinson's disease	0.00203	0.00249	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00202	0.00248	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00196	0.00241	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—HSPA8—Parkinson's disease	0.00196	0.00241	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00195	0.0024	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—DRD3—Parkinson's disease	0.00188	0.00231	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00187	0.00229	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—HSPA8—Parkinson's disease	0.00186	0.00229	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00185	0.00228	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00185	0.00228	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—DLG4—Parkinson's disease	0.00184	0.00226	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—GRIN2B—Parkinson's disease	0.0018	0.00221	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—COMT—Parkinson's disease	0.00177	0.00217	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—SLC6A3—Parkinson's disease	0.00177	0.00217	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—MAOA—Parkinson's disease	0.00176	0.00216	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—DLG4—Parkinson's disease	0.00174	0.00214	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GRIN2B—Parkinson's disease	0.00171	0.0021	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—HTR7—Parkinson's disease	0.0017	0.00209	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—SLC6A3—Parkinson's disease	0.00168	0.00207	CbGpPWpGaD
Metocurine—CHRM2—Regulation of Actin Cytoskeleton—FGF20—Parkinson's disease	0.00161	0.00198	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—GRM4—Parkinson's disease	0.00158	0.00195	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—COMT—Parkinson's disease	0.0015	0.00185	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—PENK—Parkinson's disease	0.0015	0.00184	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—MAOA—Parkinson's disease	0.00149	0.00184	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—COMT—Parkinson's disease	0.00143	0.00176	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—MAOA—Parkinson's disease	0.00142	0.00174	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GPR37—Parkinson's disease	0.00141	0.00173	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—PDYN—Parkinson's disease	0.00137	0.00169	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00136	0.00167	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00131	0.00161	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00129	0.00158	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00119	0.00147	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—HTR2A—Parkinson's disease	0.00119	0.00146	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00112	0.00138	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00109	0.00134	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00101	0.00124	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GRM4—Parkinson's disease	0.000958	0.00118	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000949	0.00117	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000941	0.00116	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000916	0.00113	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—PENK—Parkinson's disease	0.000908	0.00112	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00088	0.00108	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000873	0.00107	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000862	0.00106	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000844	0.00104	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—PDYN—Parkinson's disease	0.000831	0.00102	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000817	0.001	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000813	0.000999	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000797	0.000979	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—DRD2—Parkinson's disease	0.000796	0.000979	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000774	0.000951	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GRM5—Parkinson's disease	0.000772	0.000949	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000748	0.00092	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000739	0.000908	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000739	0.000908	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000737	0.000906	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GPR37—Parkinson's disease	0.000723	0.000889	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000723	0.000889	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000723	0.000888	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.0007	0.00086	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000662	0.000813	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000657	0.000807	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000633	0.000778	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000633	0.000778	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRK5—Parkinson's disease	0.000604	0.000742	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR1A—Parkinson's disease	0.00057	0.0007	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—TAC1—Parkinson's disease	0.000561	0.00069	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—DRD1—Parkinson's disease	0.00055	0.000677	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRK5—Parkinson's disease	0.000548	0.000674	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000542	0.000666	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—DRD3—Parkinson's disease	0.000533	0.000655	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000517	0.000636	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—VPS35—Parkinson's disease	0.000516	0.000634	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—PENK—Parkinson's disease	0.000513	0.000631	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000507	0.000623	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRM4—Parkinson's disease	0.000492	0.000604	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR7—Parkinson's disease	0.000482	0.000593	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—DRD2—Parkinson's disease	0.000482	0.000593	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—PDYN—Parkinson's disease	0.00047	0.000577	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PENK—Parkinson's disease	0.000466	0.000573	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000459	0.000564	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000458	0.000562	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000443	0.000545	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000436	0.000537	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GPR37—Parkinson's disease	0.000427	0.000525	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DGKQ—Parkinson's disease	0.000427	0.000525	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PDYN—Parkinson's disease	0.000426	0.000524	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRM5—Parkinson's disease	0.000396	0.000487	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000391	0.00048	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—EDN1—Parkinson's disease	0.000386	0.000474	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000371	0.000456	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—RIT2—Parkinson's disease	0.000342	0.00042	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR2A—Parkinson's disease	0.000338	0.000415	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000337	0.000414	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000333	0.000409	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRK5—Parkinson's disease	0.000324	0.000398	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000322	0.000396	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—TAC1—Parkinson's disease	0.000317	0.00039	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—DRD1—Parkinson's disease	0.000311	0.000382	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—DRD3—Parkinson's disease	0.000301	0.00037	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR1A—Parkinson's disease	0.000292	0.000359	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRM4—Parkinson's disease	0.00029	0.000357	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—TAC1—Parkinson's disease	0.000288	0.000354	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—DRD1—Parkinson's disease	0.000282	0.000347	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000281	0.000346	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PENK—Parkinson's disease	0.000275	0.000339	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MAG—Parkinson's disease	0.000275	0.000339	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—DRD3—Parkinson's disease	0.000274	0.000336	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—DRD2—Parkinson's disease	0.000272	0.000335	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR7—Parkinson's disease	0.000272	0.000335	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000269	0.00033	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000255	0.000314	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PDYN—Parkinson's disease	0.000252	0.00031	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR7—Parkinson's disease	0.000247	0.000304	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—DRD2—Parkinson's disease	0.000247	0.000304	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GFAP—Parkinson's disease	0.000237	0.000291	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRM5—Parkinson's disease	0.000234	0.000288	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000218	0.000268	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—FGF20—Parkinson's disease	0.000205	0.000252	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000199	0.000245	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	0.000198	0.000243	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000191	0.000235	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—INSR—Parkinson's disease	0.000184	0.000226	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—FGB—Parkinson's disease	0.000174	0.000213	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000173	0.000213	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	0.000173	0.000212	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	0.00017	0.000209	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	0.000167	0.000205	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	0.000162	0.000199	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000151	0.000185	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	0.000146	0.00018	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	0.000146	0.00018	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	0.000122	0.000151	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	0.000118	0.000146	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	0.000117	0.000144	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NGF—Parkinson's disease	0.000108	0.000132	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	0.000102	0.000126	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—APOE—Parkinson's disease	9.51e-05	0.000117	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—INS—Parkinson's disease	8.13e-05	9.99e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	6.05e-05	7.44e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	6.01e-05	7.39e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	5.56e-05	6.84e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IL6—Parkinson's disease	3.55e-05	4.37e-05	CbGpPWpGaD
